153 related articles for article (PubMed ID: 38099361)
1. Survival benefit of exenteration in COVID-19-associated rhino-orbital mucormycosis.
Raj A; Singh P; Sadhukhan K; Chandra B; Kranti B; Kumar S; Sinha U; Kokkayil P; Bhadani PP; Sinha P; Sanepalli S; Tiwari P; Nanda J
Indian J Ophthalmol; 2024 Feb; 72(2):190-194. PubMed ID: 38099361
[TBL] [Abstract][Full Text] [Related]
2. Local Infiltration Anesthesia for Orbital Exenteration in Patients With Rhino-Orbital Cerebral Mucormycosis: A Case Series.
Veerabathula P; Singh S; Koshy PG; Dave TV; Rao RN; Naik MN
A A Pract; 2022 Apr; 16(4):e01581. PubMed ID: 35421003
[TBL] [Abstract][Full Text] [Related]
3. Scoring system evaluation for orbital exenteration in patients with rhino-orbito-cerebral mucormycosis.
Ulas B; Kursun E; Turunc T; Demıroglu YZ; Pelıt A
J Fr Ophtalmol; 2022 Jan; 45(1):47-52. PubMed ID: 34823889
[TBL] [Abstract][Full Text] [Related]
4. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
[TBL] [Abstract][Full Text] [Related]
5. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
[TBL] [Abstract][Full Text] [Related]
7. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
8. Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.
Sharifi A; Akbari Z; Shafie'ei M; Nasiri N; Sharifi M; Shafiei M; Zand A
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):425-432. PubMed ID: 35943425
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M
Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
[TBL] [Abstract][Full Text] [Related]
10. Orbital exenteration: The 10-year Massachusetts Eye and Ear Infirmary experience.
Nagendran ST; Lee NG; Fay A; Lefebvre DR; Sutula FC; Freitag SK
Orbit; 2016 Aug; 35(4):199-206. PubMed ID: 27322708
[TBL] [Abstract][Full Text] [Related]
11. Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection-a case report.
Prasad S; Gaur A; Mehta A; Kaushal N
BMC Ophthalmol; 2022 Oct; 22(1):389. PubMed ID: 36183076
[TBL] [Abstract][Full Text] [Related]
12. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
[TBL] [Abstract][Full Text] [Related]
13. Rise of the phoenix: Mucormycosis in COVID-19 times.
Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
[TBL] [Abstract][Full Text] [Related]
14. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
[TBL] [Abstract][Full Text] [Related]
16. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
17. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis.
Arora R; Goel R; Meher R
JAMA Ophthalmol; 2022 May; 140(5):548. PubMed ID: 35389467
[No Abstract] [Full Text] [Related]
18. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis-Reply.
Date PS; Choksi T; Ingole AB
JAMA Ophthalmol; 2022 May; 140(5):548-549. PubMed ID: 35389457
[No Abstract] [Full Text] [Related]
19. Exploring the globe salvaging treatment options in patients of COVID-19-associated mucormycosis with orbital involvement.
Khare P; Chaurasia Y; Bhatnagar S
Indian J Ophthalmol; 2022 Oct; 70(10):3638-3642. PubMed ID: 36190063
[TBL] [Abstract][Full Text] [Related]
20. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis.
Luna JD; Ponssa XS; Rodríguez SD; Luna NC; Juárez CP
Ophthalmic Surg Lasers; 1996 Aug; 27(8):706-8. PubMed ID: 8858637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]